Drug Profile
Research programme: DNA vaccines - Inovio/Wistar Institute
Alternative Names: SynCon® vaccines - InovioLatest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator Inovio Pharmaceuticals
- Developer Inovio Pharmaceuticals; Wistar Institute
- Class Antimalarials; Antituberculars; DNA vaccines; Malaria vaccines; Tuberculosis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malaria; Tuberculosis